bmcgastroenterol.biomedcentral.com
Cure8 news brief
Why This Matters
People with Crohn’s disease who have an ileostomy have limited noninvasive ways to monitor small-bowel inflammation. This study suggests measuring fecal calprotectin from ileostomy output could help detect postoperative inflammation and guide follow-up decisions.
Who Should Pay Attention
Patients with Crohn’s disease and an ileostomy; gastroenterologists and surgeons who manage postoperative IBD; researchers studying IBD biomarkers.
Study Snapshot
Story typeResearch paper
Evidence typeClinical study
Source depthFull source text
What To Know
This study looked at whether fecal calprotectin (FC) measured from ileostomy output can help detect small-bowel inflammation after surgery in people with Crohn’s disease.
The researchers compared FC results from point-of-care (POC) tests and ELISA with imaging and/or ileoscopy findings in a retrospective cohort and found higher FC levels when imaging/endoscopy showed inflammation.
The paper reports that FC from ileostomy output showed good sensitivity and specificity for detecting postoperative small-bowel inflammation and compares performance between ELISA and rapid POC tests. This was a single-center, retrospective analysis of patients with ileostomy who had paired FC and imaging/endoscopic assessments.
Keep In Mind
Retrospective single-center study comparing FC from ileostomy output to imaging and/or ileoscopy. Findings support FC as a sensitive marker but require validation in larger, prospective cohorts and consideration of assay differences (ELISA vs POC) before changing practice.
Source Details
Review the original publication for the complete reporting, methods, and context.
Clinical study
Article type assigned from Cure8 classification; confirm details in the original source.
Publicationbmcgastroenterol.biomedcentral.com
Indexed viaGoogle News
Source typeResearch paper
PublishedFeb 13, 2025, 3:06 PM
Content availableFull source text
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Monitoring Crohn's Disease After Surgery with Fecal Calprotectin - Physician's Weekly
People with Crohn's disease who have an ileostomy need reliable, noninvasive tools to monitor for postoperative small-bowel inflammation. This study suggests fecal calprotectin measured from ileostomy output may help...
Faecal Calprotectin Predicts Inflammation in Crohn’s Disease
Faecal calprotectin from ileostomy output could provide a non-invasive way to detect small-bowel inflammation after surgery, helping to guide monitoring and reduce reliance on invasive tests for postoperative Crohn’s...
Wolfe Highlights Differentiation Potential in Palisade Bio, Inc. (PALI) Clinical Profile
Early clinical data suggest PALI-2108 may affect both inflammation and fibrosis in Crohn’s disease and shows biomarker changes (like fecal calprotectin) that could matter to people monitoring disease activity.